U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775898) titled 'Behavioural Test for Early Glaucoma' on Aug. 17.
Brief Summary: Glaucoma-related blindness often results from delayed diagnosis, largely due to the disease's gradual onset, it's early manifestation predominantly in peripheral vision, and the limited sensitivity of current detection methods for its early stages (Stein et al., 2021). This project aims to determine whether early functional loss can be identified using a novel psychophysical task based on perception of contrast-modulated visual stimuli, which reflects the functionality of the retinal neurons thought to be earliest affected in glaucoma (Ramirez et al., 2022). As a proof ...